Cadre profit margin CDRE
Gross, operating and net profit as a share of revenue over the last twelve months, from 2021.
- Net margin, 12 months
- 5.3%
- Operating margin, 12 months
- 10.1%
- Net margin on a year earlier
- −1.4 pts
- Peer median
- 7.7%
Over the twelve months to Jun 30, 2026, Cadre kept 5.3% of its revenue as net profit, with an operating margin of 10.1% and a gross margin of 41.8%.
Five years earlier its net margin was 8.2%.
The median for 10 medical instruments and supplies stocks of a similar size is 7.7%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 7.2% | 11.0% | 42.5% |
| FY2024 | 6.4% | 11.8% | 41.1% |
| FY2023 | 8.0% | 11.7% | 41.6% |
| FY2022 | 1.3% | 3.7% | 38.4% |
| FY2021 | 3.0% | 12.1% | 39.9% |
| FY2020 | n/a | n/a | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 5.3% | −1.4 pts | 10.1% | |
| Q1 FY26 | 5.8% | −1.1 pts | 9.6% | |
| Q4 FY25 | 7.2% | +0.9 pts | 11.0% | |
| Q3 FY25 | 7.3% | +1.0 pts | 12.3% | |
| Q2 FY25 | 6.7% | −0.9 pts | 11.0% | |
| Q1 FY25 | 6.9% | −0.7 pts | 12.2% | |
| Q4 FY24 | 6.4% | −1.6 pts | 11.8% | |
| Q3 FY24 | 6.3% | −1.1 pts | 9.7% | |
| Q2 FY24 | 7.5% | +1.2 pts | 11.5% | |
| Q1 FY24 | 7.6% | +2.6 pts | 11.3% | |
| Q4 FY23 | 8.0% | +6.7 pts | 11.7% | |
| Q3 FY23 | 7.4% | +6.6 pts | 11.7% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Cadre's size, closest first, today.
| Company | Profit margin |
|---|---|
| CDRECadre | 5.3% |
| BVSBioventus | 9.4% |
| STAAStaar Surgical | 1.1% |
| EYENational Vision | 2.5% |
| IRMDIradimed | 26.7% |
| LMATLemaitre Vascular | 25.0% |
| INSPInspire Medical Systems | 15.0% |
| UFPTUFP Technologies | 11.4% |
| MOVMovado | 6.0% |
| MDXGMimedx | 1.8% |
| ATRCAtriCure | 1.9% |
| Peer median | 7.7% |
Where Cadre ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Cadre
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.